Your Location：
Home >
Browse articles >
Dual-locked targeted alpha-emitter enhanced tumor immunotherapy via Diels–Alder reaction-based self-immolative molecular cage strategy
RESEARCH | Updated：2026-06-10

    • Dual-locked targeted alpha-emitter enhanced tumor immunotherapy via Diels–Alder reaction-based self-immolative molecular cage strategy

    • Military Medical Research   Vol. 13, Issue 5, Pages: 728-746(2026)

    • DOI：10.1186/s40779-025-00673-5    

      CLC：

    • Received：14 May 2025，

      Accepted：13 November 2025，

      Online First：01 December 2025，

      Published：2026-05

    Scan QR Code

  • Meng-Die Yang, Kang Fang, Xiao-Yi Zhang, et al. Dual-locked targeted alpha-emitter enhanced tumor immunotherapy via Diels–Alder reaction-based self-immolative molecular cage strategy[J]. Military Medical Research, 2026, 13(5): 728-746. DOI： 10.1186/s40779-025-00673-5.

  •  
  •  

0

Views

14

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Identification of the lymph node metastasis atlas and optimal lymph node dissection strategy in patients with resectable lung invasive mucinous adenocarcinoma: a real-world multicenter study
TNC-targeted CAR-macrophage therapy alleviates liver fibrosis in mice
The "cytokine storm" in infection and sepsis:win the battle but lose the war
Cell-free DNA in sepsis: from molecular insights to clinical management
PRIME: an interpretable artificial intelligence model based on liquid biopsy improves prediction of progression risk in non-small cell lung cancer

Related Author

No data

Related Institution

No data
0